EMA grants Orphan Drug Designation to Saroglitazar Mg for treating patients with PBC
The Orphan drug status in Europe is given to medicines with the potential to be safe and effective treatments for rare,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.